Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity.

Huaxia Xie, Longfei Mao, Gaolu Fan, Ziyuan Wu, Yimian Wang, Xixi Hou, Jiangang Wang, Huili Wang, Ling Liu, Sanqiang Li
Author Information
  1. Huaxia Xie: College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
  2. Longfei Mao: College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
  3. Gaolu Fan: Department of Pharmacy, Luoyang Third People's Hospital, Luoyang, China.
  4. Ziyuan Wu: College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
  5. Yimian Wang: College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
  6. Xixi Hou: Department of Pharmacy, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.
  7. Jiangang Wang: College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
  8. Huili Wang: University of North Carolina Hospitals, Chapel Hill, NC, United States.
  9. Ling Liu: College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.
  10. Sanqiang Li: College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, China.

Abstract

Based on the structure of the anti-HIV drug cabotegravir, we introduced 1,2,3-triazole groups with different substituents to obtain 19 cabotegravir derivatives and tested their activity against HepG2 cells. The proliferation of HepG2 cells was examined following treatment with derivatives. Most of the compounds demonstrated significant inhibitory effects, particularly compounds KJ-5 and KJ-12 with IC values of 4.29 �� 0.10 and 4.07 �� 0.09 ��M, respectively. Furthermore, both compounds 5 and 12 significantly caused cell apoptosis, G2/M arrest, and DNA damage, and suppressed invasion and migration in a concentration-dependent manner. In addition, KJ-5 and KJ-12 could trigger apoptosis via the mitochondrial pathway by increasing the ratio of Bax/Bcl-2 and activating cleaved caspase-9, cleaved caspase-3, and cleaved PARP.

Keywords

References

  1. Front Microbiol. 2023 Jan 19;13:1029412 [PMID: 36741886]
  2. Curr Opin HIV AIDS. 2015 Jul;10(4):258-63 [PMID: 26049951]
  3. Cancer Treat Res. 2007;133:241-52 [PMID: 17672044]
  4. Heliyon. 2019 Sep 06;5(9):e02408 [PMID: 31517128]
  5. Chem Biol Drug Des. 2018 Jul;92(1):1301-1314 [PMID: 29575727]
  6. J Med Chem. 2017 Feb 9;60(3):987-999 [PMID: 28107629]
  7. J Med Chem. 2013 Jul 25;56(14):5901-16 [PMID: 23845180]
  8. J Med Chem. 2015 Sep 24;58(18):7186-94 [PMID: 26348784]
  9. Bioorg Chem. 2020 Dec;105:104421 [PMID: 33181408]
  10. Biochemistry. 2021 Jun 8;60(22):1731-1740 [PMID: 34029457]
  11. Pharmaceuticals (Basel). 2022 Apr 20;15(5): [PMID: 35631331]
  12. Front Pharmacol. 2022 Apr 20;13:849364 [PMID: 35517789]
  13. ACS Appl Mater Interfaces. 2022 Dec 7;14(48):53475-53490 [PMID: 36413755]
  14. Front Pharmacol. 2020 Sep 30;11:579024 [PMID: 33101032]
  15. Eur J Med Chem. 2019 Mar 1;165:309-322 [PMID: 30690300]
  16. J Med Chem. 2019 Oct 10;62(19):8784-8795 [PMID: 31525930]
  17. Bioorg Chem. 2020 Jan;94:103392 [PMID: 31669093]
  18. Bioorg Chem. 2020 Nov;104:104272 [PMID: 32961467]
  19. Eur J Med Chem. 2018 Jan 1;143:1535-1542 [PMID: 29126726]